$MANKIND

$MANKIND The revenue for Mankind Pharma has shown an increase in the recent quarters. The revenue for the quarter ending June 2025 stood at Rs 3,570.35 Crore, up from Rs 2,893.42 Crore in June 2024. Similarly, the net profit for the quarter ending June 2025 was Rs 441.45 Crore, compared to Rs 539.16 Crore in June ***** annual financial results show a consistent increase in revenue and net profit over the years. The revenue for the year ending 2025 was Rs 12,207.44 Crore, compared to Rs 6,214.43 Crore in 2021. The net profit for the year ending March 2025 stood at Rs 1,994.35 Crore, increased from Rs 1,281.36 Crore in ***** standalone annual income statement shows that sales increased from Rs 5,529 Crore in March 2021 to Rs 9,497 Crore in March 2025. The net profit also increased from Rs 1,084 Crore in March 2021 to Rs 1,884 Crore in March ***** standalone quarterly income statement shows sales of Rs 2,541 Crore for June 2025 compared to Rs 2,403 Crore for June 2024. The net profit was Rs 412 Crore for June 2025 compared to Rs 513 Crore for June ***** August 19, 2025, the company announced updates on the acquisition, specifically the incorporation of a wholly-owned subsidiary in Russia.